Cancer Drug Mark-Ups Rise Up to 700% Despite 2019 Price Cuts
Despite government price cuts on cancer drugs in 2019, mark-ups on these medicines have surged to as much as 700% by 2026. This sharp increase raises concerns about the effectiveness of one-time price reductions in keeping cancer treatment affordable for patients over the long term.
Economic Times·



